Specialties

Vaccine Highlights

Specialties

Vaccine

Velocity Clinical sites have extensive experience in vaccine trials, with over 400 completed studies. Access to diverse patient populations, high volume enrollment strategies and PBMC capabilities are just a few success criteria. More information about experience and vaccine capabilities are described below.

Dots image

Vaccine Experience

Stat icon

408

Total Completed Studies

Stat icon

24936

Enrolled Study Participants

Stat icon

13

Vaccine Sites

Stat icon

29

BARDA Funded Programs

Stat icon

13

Active IBC Registered Sites

Stat icon

3

Sties with PBMC Capabilities

Respiratory Vaccine Experience

125

Completed Influenza Studies

30

Completed Pneumonia Studies

26

Completed RSV Studies

19

Completed COVID-19 Studies

Vaccine Experience: Indication

  • Avian Influenza
  • Anthrax
  • C-Diff
  • Celiac Disease
  • Chikungunya
  • Dengue
  • Ebola
  • HCMV
  • Hepatitis B
  • Herpes
  • Zoster
  • HPV
  • Influenza
  • Meningitis
  • Norovirus
  • Pandemic
  • Influenza
  • (H7N1)
  • Pediatric Influenza
  • Pneumonia
  • Respiratory Syncytial Virus
  • Seasonal Influenza
  • Smallpox
  • Swine Influenza H1N1
  • Tetanus
  • Diptheria
  • Pertussis
  • COVID-19

Capabilities

Patients

  • Highly Diverse demographics
  • Group enrollment
  • Access to Pediatric and Elderly Populations

Operations

  • Rapid Study Start Up
  • Creative use of social media and other recruitment strategies
  • Innovative approaches to high volume enrollment

Facilities

  • Controlled access for Study Drug with broad range of temperature storage
  • PBMC Capabilities and Experience
  • Fully compliant with all regulations